NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC

Differentiation. 2018 Nov-Dec:104:36-41. doi: 10.1016/j.diff.2018.10.003. Epub 2018 Oct 29.

Abstract

Endochondral ossification is the process by which long bones are formed; the process of long bone formation is regulated by numerous factors such as transcription factors, cytokines, and extracellular matrix molecules. Human hormone Nuclear receptors (hHNR) are a family of ligand-regulated transcription factors that are activated by steroid hormones, such as estrogen and progesterone, and various lipid-soluble signals, including retinoic acid, oxysterols, and thyroid hormone. Whole genome microarray data from our previous study revealed that most hHNR's are up-regulated during osteoblast differentiation in hMSCS. NR2F1 was among the highest expressed hHNR during osteogenesis, NR2F1 belongs to the steroid/thyroid hormone nuclear receptor superfamily. NR2F1 is designated as an orphan nuclear receptor because its ligands are unknown. NR2F1 plays a wide range of roles, including cell differentiation, cancer progression, and central and peripheral neurogenesis. Identifying signaling networks involved in osteoblast differentiation is important in orchestrating new therapeutic and clinical applications in bone biology. This study aimed to identify alterations in signaling networks mediated by NR2F1 in osteoblast differentiation. siRNA-mediated down-regulation of NR2F1 leads to impairment in the differentiation of hBMSC-TERT to osteoblast; gene-expression results confirmed the down-regulation of osteoblast markers such as RUNX2, ALPL, OSC, and BSP. Global whole gene expression analysis revealed that most down-regulated genes were associated with osteoblast differentiation (DDIT3, BMP2). Pathway analysis revealed prominent signaling pathways that were down-regulated, including the TGFβ pathway and MAPK pathway. Functional studies on NR2F1 transfected cells, during osteoblast differentiation in combination with TGFβ1 and BMP-2, showed that TGFβ1 does not recover osteoblast differentiation, whereas BMP-2 rescues osteoblast differentiation in NR2F1 siRNA transfected cells. Thus, our results showed that BMP-2 could intervene in NR2F1 down-regulated signaling pathways to recover osteoblast differentiation.

Keywords: BMP2 signaling; DDIT3; Human bone marrow MSCs; NR2F1; Osteogenesis; TGFb1 signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Development / genetics
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / metabolism
  • Bone Morphogenetic Protein 2 / genetics*
  • COUP Transcription Factor I / genetics*
  • Cell Differentiation / genetics*
  • Gene Expression Regulation, Developmental
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Osteoblasts / cytology
  • Osteoblasts / metabolism
  • RNA, Small Interfering / genetics
  • Signal Transduction / genetics
  • Transfection
  • Transforming Growth Factor beta1 / genetics*

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • COUP Transcription Factor I
  • NR2F1 protein, human
  • RNA, Small Interfering
  • Transforming Growth Factor beta1